Aytu BioPharma annual meeting elects all directors, ratifies auditor, approves say-on-pay

AYTU BIOPHARMA, INC

All five incumbent directors elected with majority votes; Joshua Disbrow received 2,111,846 for, 596,291 withheld.
Ratification of Grant Thornton as auditor for FY 2024 approved: 3,290,868 for, 683,165 against.
Non-binding advisory vote on executive compensation approved: 1,978,765 for, 659,394 against.
Quorum of 73% (4,037,162 shares) represented at the June 26, 2024 meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.